{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,4]],"date-time":"2026-05-04T03:43:56Z","timestamp":1777866236837,"version":"3.51.4"},"reference-count":47,"publisher":"Elsevier BV","issue":"9","license":[{"start":{"date-parts":[[2021,3,1]],"date-time":"2021-03-01T00:00:00Z","timestamp":1614556800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,3,1]],"date-time":"2021-03-01T00:00:00Z","timestamp":1614556800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,1,22]],"date-time":"2021-01-22T00:00:00Z","timestamp":1611273600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100000780","name":"European Commission","doi-asserted-by":"publisher","award":["643,381"],"award-info":[{"award-number":["643,381"]}],"id":[{"id":"10.13039\/501100000780","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100010269","name":"Wellcome Trust","doi-asserted-by":"publisher","award":["WT 206331\/Z\/17\/Z"],"award-info":[{"award-number":["WT 206331\/Z\/17\/Z"]}],"id":[{"id":"10.13039\/100010269","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2021,3]]},"DOI":"10.1016\/j.vaccine.2021.01.034","type":"journal-article","created":{"date-parts":[[2021,2,5]],"date-time":"2021-02-05T02:26:59Z","timestamp":1612492019000},"page":"1452-1462","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":21,"title":["Using an effective TB vaccination regimen to identify immune responses associated with protection in the murine model"],"prefix":"10.1016","volume":"39","author":[{"given":"Nawamin","family":"Pinpathomrat","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Naomi","family":"Bull","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Janet","family":"Pasricha","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rachel","family":"Harrington-Kandt","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Helen","family":"McShane","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Elena","family":"Stylianou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.vaccine.2021.01.034_b0005","first-page":"2019","author":"Shameer","year":"2019","journal-title":"WHO. Global tuberculosis report"},{"issue":"6","key":"10.1016\/j.vaccine.2021.01.034_b0010","doi-asserted-by":"crossref","first-page":"1154","DOI":"10.1093\/ije\/22.6.1154","article-title":"Protective effect of BCG against tuberculous meningitis and miliary tuberculosis: a meta-analysis","volume":"22","author":"Rodrigues","year":"1993","journal-title":"Int J Epidemiol."},{"issue":"13","key":"10.1016\/j.vaccine.2021.01.034_b0015","doi-asserted-by":"crossref","first-page":"2869","DOI":"10.1084\/jem.20100090","article-title":"Preferential infection and depletion of Mycobacterium tuberculosis-specific CD4 T cells after HIV-1 infection","volume":"207","author":"Geldmacher","year":"2010","journal-title":"J Exp Med"},{"issue":"11","key":"10.1016\/j.vaccine.2021.01.034_b0020","doi-asserted-by":"crossref","first-page":"1590","DOI":"10.1086\/593017","article-title":"Early depletion of Mycobacterium tuberculosis-specific T helper 1 cell responses after HIV-1 infection","volume":"198","author":"Geldmacher","year":"2008","journal-title":"J Infect Dis."},{"issue":"3","key":"10.1016\/j.vaccine.2021.01.034_b0025","first-page":"268","article-title":"Interaction between HIV and Mycobacterium tuberculosis: HIV-1-induced CD4 T-cell depletion and the development of active tuberculosis","volume":"7","author":"Geldmacher","year":"2012","journal-title":"Curr Opin HIV AIDS."},{"key":"10.1016\/j.vaccine.2021.01.034_b0030","doi-asserted-by":"crossref","first-page":"1633","DOI":"10.3389\/fimmu.2017.01633","article-title":"Type I Interferons in the Pathogenesis of Tuberculosis: Molecular Drivers and Immunological Consequences","volume":"8","author":"Donovan","year":"2017","journal-title":"Front Immunol."},{"issue":"3","key":"10.1016\/j.vaccine.2021.01.034_b0035","doi-asserted-by":"crossref","first-page":"1780","DOI":"10.4049\/jimmunol.177.3.1780","article-title":"Phenotypical and functional analysis of memory and effector human CD8 T cells specific for mycobacterial antigens","volume":"177","author":"Caccamo","year":"2006","journal-title":"J Immunol."},{"issue":"5386","key":"10.1016\/j.vaccine.2021.01.034_b0040","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1126\/science.282.5386.121","article-title":"An antimicrobial activity of cytolytic T cells mediated by granulysin","volume":"282","author":"Stenger","year":"1998","journal-title":"Science"},{"issue":"4","key":"10.1016\/j.vaccine.2021.01.034_b0045","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1000392","article-title":"A critical role for CD8 T cells in a nonhuman primate model of tuberculosis","volume":"5","author":"Chen","year":"2009","journal-title":"PLoS Pathog."},{"key":"10.1016\/j.vaccine.2021.01.034_b0050","doi-asserted-by":"crossref","first-page":"11290","DOI":"10.1038\/ncomms11290","article-title":"T-cell activation is an immune correlate of risk in BCG vaccinated infants","volume":"7","author":"Fletcher","year":"2016","journal-title":"Nat Commun."},{"issue":"4","key":"10.1016\/j.vaccine.2021.01.034_b0055","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1038\/nri778","article-title":"Effector and memory T-cell differentiation: implications for vaccine development","volume":"2","author":"Kaech","year":"2002","journal-title":"Nat Rev Immunol."},{"issue":"4","key":"10.1016\/j.vaccine.2021.01.034_b0060","doi-asserted-by":"crossref","first-page":"618","DOI":"10.1128\/CVI.00368-09","article-title":"Phenotypic definition of effector and memory T-lymphocyte subsets in mice chronically infected with Mycobacterium tuberculosis","volume":"17","author":"Henao-Tamayo","year":"2010","journal-title":"Clin Vaccine Immunol."},{"issue":"5","key":"10.1016\/j.vaccine.2021.01.034_b0065","doi-asserted-by":"crossref","first-page":"2059","DOI":"10.4049\/jimmunol.1402256","article-title":"Cutting edge: CD69 interference with sphingosine-1-phosphate receptor function regulates peripheral T cell retention","volume":"194","author":"Mackay","year":"2015","journal-title":"J Immunol."},{"issue":"11","key":"10.1016\/j.vaccine.2021.01.034_b0070","doi-asserted-by":"crossref","first-page":"5510","DOI":"10.4049\/jimmunol.1102243","article-title":"Cutting edge: Tissue-retentive lung memory CD4 T cells mediate optimal protection to respiratory virus infection","volume":"187","author":"Teijaro","year":"2011","journal-title":"J Immunol."},{"issue":"3","key":"10.1016\/j.vaccine.2021.01.034_b0075","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1038\/mi.2013.67","article-title":"Lung niches for the generation and maintenance of tissue-resident memory T cells","volume":"7","author":"Turner","year":"2014","journal-title":"Mucosal Immunol."},{"issue":"1","key":"10.1016\/j.vaccine.2021.01.034_b0080","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1038\/nprot.2014.005","article-title":"Intravascular staining for discrimination of vascular and tissue leukocytes","volume":"9","author":"Anderson","year":"2014","journal-title":"Nat Protoc."},{"issue":"7","key":"10.1016\/j.vaccine.2021.01.034_b0085","doi-asserted-by":"crossref","first-page":"2965","DOI":"10.4049\/jimmunol.1400019","article-title":"Cutting edge: control of Mycobacterium tuberculosis infection by a subset of lung parenchyma-homing CD4 T cells","volume":"192","author":"Sakai","year":"2014","journal-title":"J Immunol."},{"issue":"7424","key":"10.1016\/j.vaccine.2021.01.034_b0090","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1038\/nature11522","article-title":"A vaccine strategy that protects against genital herpes by establishing local memory T cells","volume":"491","author":"Shin","year":"2012","journal-title":"Nature"},{"issue":"2","key":"10.1016\/j.vaccine.2021.01.034_b0095","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1038\/mi.2016.70","article-title":"Subunit vaccine H56\/CAF01 induces a population of circulating CD4 T cells that traffic into the Mycobacterium tuberculosis-infected lung","volume":"10","author":"Woodworth","year":"2017","journal-title":"Mucosal Immunol."},{"key":"10.1016\/j.vaccine.2021.01.034_b0100","article-title":"Enhanced protection conferred by mucosal BCG vaccination associates with presence of antigen-specific lung tissue-resident PD-1(+) KLRG1(-) CD4(+) T cells","author":"Bull","year":"2018","journal-title":"Mucosal Immunol"},{"issue":"37","key":"10.1016\/j.vaccine.2021.01.034_b0105","doi-asserted-by":"crossref","first-page":"5625","DOI":"10.1016\/j.vaccine.2018.07.035","article-title":"Induction and maintenance of a phenotypically heterogeneous lung tissue-resident CD4(+) T cell population following BCG immunisation","volume":"36","author":"Bull","year":"2018","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2021.01.034_b0110","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1016\/j.tube.2014.10.008","article-title":"Vaccines to prevent tuberculosis infection rather than disease: Physiological and immunological aspects","volume":"101","author":"Orme","year":"2016","journal-title":"Tuberculosis."},{"issue":"3","key":"10.1016\/j.vaccine.2021.01.034_b0115","doi-asserted-by":"crossref","first-page":"514","DOI":"10.1128\/CMR.11.3.514","article-title":"Serum therapy for tuberculosis revisited: reappraisal of the role of antibody-mediated immunity against Mycobacterium tuberculosis","volume":"11","author":"Glatman-Freedman","year":"1998","journal-title":"Clin Microbiol Rev."},{"issue":"3","key":"10.1016\/j.vaccine.2021.01.034_b0120","first-page":"449","article-title":"PPD-specific IgG1 antibody subclass upregulate tumour necrosis factor expression in PPD-stimulated monocytes: possible link with disease pathogenesis in tuberculosis","volume":"119","author":"Hussain","year":"2000","journal-title":"Clin Exp Immunol."},{"issue":"20","key":"10.1016\/j.vaccine.2021.01.034_b0125","first-page":"2565","article-title":"Role of IgA in the defense against respiratory infections IgA deficient mice exhibited increased susceptibility to intranasal infection with Mycobacterium bovis BCG","volume":"23","author":"Rodriguez","year":"2005","journal-title":"Vaccine."},{"issue":"9","key":"10.1016\/j.vaccine.2021.01.034_b0130","doi-asserted-by":"crossref","first-page":"992","DOI":"10.1128\/CVI.00289-15","article-title":"Evaluation of the Immunogenicity of Mycobacterium bovis BCG Delivered by Aerosol to the Lungs of Macaques","volume":"22","author":"White","year":"2015","journal-title":"Clin Vaccine Immunol."},{"issue":"6","key":"10.1016\/j.vaccine.2021.01.034_b0135","doi-asserted-by":"crossref","first-page":"2900","DOI":"10.4049\/jimmunol.1500981","article-title":"Role of B Cells in Mucosal Vaccine-Induced Protective CD8+ T Cell Immunity against Pulmonary Tuberculosis","volume":"195","author":"Khera","year":"2015","journal-title":"J Immunol."},{"issue":"11","key":"10.1016\/j.vaccine.2021.01.034_b0140","doi-asserted-by":"crossref","first-page":"4071","DOI":"10.1128\/IAI.00786-13","article-title":"Mucosal Vaccination against Tuberculosis Using Inert Bioparticles","volume":"81","author":"Reljic","year":"2013","journal-title":"Infect Immun"},{"issue":"2","key":"10.1016\/j.vaccine.2021.01.034_b0145","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1002\/eji.201343887","article-title":"Mucosal delivery of antigen-coated nanoparticles to lungs confers protective immunity against tuberculosis infection in mice","volume":"44","author":"Stylianou","year":"2014","journal-title":"Eur J Immunol"},{"issue":"11","key":"10.1016\/j.vaccine.2021.01.034_b0150","doi-asserted-by":"crossref","first-page":"1240","DOI":"10.1038\/nm1128","article-title":"Recombinant modified vaccinia virus Ankara expressing antigen 85A boosts BCG-primed and naturally acquired antimycobacterial immunity in humans","volume":"10","author":"McShane","year":"2004","journal-title":"Nat Med."},{"issue":"12","key":"10.1016\/j.vaccine.2021.01.034_b0155","doi-asserted-by":"crossref","first-page":"1832","DOI":"10.1093\/infdis\/jir195","article-title":"Dose-finding study of the novel tuberculosis vaccine, MVA85A, in healthy BCG-vaccinated infants","volume":"203","author":"Scriba","year":"2011","journal-title":"J Infect Dis."},{"issue":"9871","key":"10.1016\/j.vaccine.2021.01.034_b0160","doi-asserted-by":"crossref","first-page":"1021","DOI":"10.1016\/S0140-6736(13)60177-4","article-title":"Safety and efficacy of MVA85A, a new tuberculosis vaccine, in infants previously vaccinated with BCG: a randomised, placebo-controlled phase 2b trial","volume":"381","author":"Tameris","year":"2013","journal-title":"Lancet"},{"issue":"7","key":"10.1016\/j.vaccine.2021.01.034_b0165","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0040385","article-title":"A novel chimpanzee adenovirus vector with low human seroprevalence: improved systems for vector derivation and comparative immunogenicity","volume":"7","author":"Dicks","year":"2012","journal-title":"PLoS ONE"},{"issue":"48","key":"10.1016\/j.vaccine.2021.01.034_b0170","doi-asserted-by":"crossref","first-page":"6800","DOI":"10.1016\/j.vaccine.2015.10.017","article-title":"Improvement of BCG protective efficacy with a novel chimpanzee adenovirus and a modified vaccinia Ankara virus both expressing Ag85A","volume":"33","author":"Stylianou","year":"2015","journal-title":"Vaccine."},{"issue":"6","key":"10.1016\/j.vaccine.2021.01.034_b0175","doi-asserted-by":"crossref","first-page":"2702","DOI":"10.4049\/jimmunol.1201682","article-title":"Cutting edge: intravascular staining redefines lung CD8 T cell responses","volume":"189","author":"Anderson","year":"2012","journal-title":"J Immunol."},{"issue":"6","key":"10.1016\/j.vaccine.2021.01.034_b0180","doi-asserted-by":"crossref","DOI":"10.1128\/mBio.01686-16","article-title":"Mucosal BCG Vaccination Induces Protective Lung-Resident Memory T Cell Populations against Tuberculosis","volume":"7","author":"Perdomo","year":"2016","journal-title":"MBio."},{"issue":"7","key":"10.1016\/j.vaccine.2021.01.034_b0185","doi-asserted-by":"crossref","first-page":"2555","DOI":"10.4049\/jimmunol.1700382","article-title":"CXCR3 Signaling Is Required for Restricted Homing of Parenteral Tuberculosis Vaccine-Induced T Cells to Both the Lung Parenchyma and Airway","volume":"199","author":"Jeyanathan","year":"2017","journal-title":"J Immunol."},{"issue":"10","key":"10.1016\/j.vaccine.2021.01.034_b0190","doi-asserted-by":"crossref","first-page":"6357","DOI":"10.4049\/jimmunol.173.10.6357","article-title":"Single mucosal, but not parenteral, immunization with recombinant adenoviral-based vaccine provides potent protection from pulmonary tuberculosis","volume":"173","author":"Wang","year":"2004","journal-title":"J Immunol."},{"issue":"8","key":"10.1016\/j.vaccine.2021.01.034_b0195","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0135009","article-title":"AdHu5Ag85A Respiratory Mucosal Boost Immunization Enhances Protection against Pulmonary Tuberculosis in BCG-Primed Non-Human Primates","volume":"10","author":"Jeyanathan","year":"2015","journal-title":"PLoS ONE"},{"issue":"7788","key":"10.1016\/j.vaccine.2021.01.034_b0200","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1038\/s41586-019-1817-8","article-title":"Prevention of tuberculosis in macaques after intravenous BCG immunization","volume":"577","author":"Darrah","year":"2020","journal-title":"Nature"},{"key":"10.1016\/j.vaccine.2021.01.034_b0205","doi-asserted-by":"crossref","DOI":"10.1128\/IAI.00014-18","article-title":"Identification and Evaluation of Novel Protective Antigens for the Development of a Candidate TB Subunit Vaccine","author":"Stylianou","year":"2018","journal-title":"Infect Immun"},{"issue":"9","key":"10.1016\/j.vaccine.2021.01.034_b0210","doi-asserted-by":"crossref","first-page":"1121","DOI":"10.1016\/j.vaccine.2015.01.042","article-title":"The relative magnitude of transgene-specific adaptive immune responses induced by human and chimpanzee adenovirus vectors differs between laboratory animals and a target species","volume":"33","author":"Dicks","year":"2015","journal-title":"Vaccine."},{"issue":"5","key":"10.1016\/j.vaccine.2021.01.034_b0215","doi-asserted-by":"crossref","first-page":"e01921","DOI":"10.1128\/mBio.01921-14","article-title":"Mycobacterial membrane vesicles administered systemically in mice induce a protective immune response to surface compartments of Mycobacterium tuberculosis","volume":"5","author":"Prados-Rosales","year":"2014","journal-title":"MBio."},{"issue":"25\u201326","key":"10.1016\/j.vaccine.2021.01.034_b0220","doi-asserted-by":"crossref","first-page":"4081","DOI":"10.1016\/S0264-410X(03)00274-3","article-title":"Mycobacterium tuberculosis arabinomannan-protein conjugates protect against tuberculosis","volume":"21","author":"Hamasur","year":"2003","journal-title":"Vaccine."},{"key":"10.1016\/j.vaccine.2021.01.034_b0225","doi-asserted-by":"crossref","first-page":"15018","DOI":"10.1038\/mtm.2015.18","article-title":"Mucosal delivery of a vectored RSV vaccine is safe and elicits protective immunity in rodents and nonhuman primates","volume":"2","author":"Pierantoni","year":"2015","journal-title":"Molecular therapy Methods & clinical development."},{"issue":"19","key":"10.1016\/j.vaccine.2021.01.034_b0230","doi-asserted-by":"crossref","first-page":"5023","DOI":"10.1073\/pnas.1611776114","article-title":"Latently and uninfected healthcare workers exposed to TB make protective antibodies against Mycobacterium tuberculosis","volume":"114","author":"Li","year":"2017","journal-title":"Proc Natl Acad Sci U S A."},{"issue":"2","key":"10.1016\/j.vaccine.2021.01.034_b0235","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1128\/IAI.69.2.681-686.2001","article-title":"Enhanced immunogenicity of CD4(+) t-cell responses and protective efficacy of a DNA-modified vaccinia virus Ankara prime-boost vaccination regimen for murine tuberculosis","volume":"69","author":"McShane","year":"2001","journal-title":"Infect Immun."}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X21000505?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X21000505?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,4,30]],"date-time":"2026-04-30T08:16:20Z","timestamp":1777536980000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X21000505"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,3]]},"references-count":47,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2021,3]]}},"alternative-id":["S0264410X21000505"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2021.01.034","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2021,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Using an effective TB vaccination regimen to identify immune responses associated with protection in the murine model","name":"articletitle","label":"Article Title"},{"value":"Vaccine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.vaccine.2021.01.034","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 The Author(s). Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}]}}